Observe Medical
ISIN: NO0010865009 | Ticker: OBSRV | LEI: 9845005F38B74FFJ1B65
Country: Norway
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increase clinical data accuracy and promoting positive health economics.
Observe Medical has a global network and reach and commercialises proprietary and innovative medtech products. With a growing portfolio of products on the market and expanded portfolio for direct sales, the company has a solid platform for further organic growth through targeted M&A.
The company seeks to drive growth by leveraging its expertise in sales and commercialisation and has a broad portfolio of medtech products, mainly across Urology/ICU (revolutionary urine measurement systems), ultrasound, anaesthesiology/ICUs, surgery and wound care.
2009
Served areaWorldwide
HeadquartersHenrik Ibsens gate 90, 0255 Oslo – Norway
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 87,733,000.00 | 71,738,000.00 | 215,812,000.00 |
| Noncurrent Assets | N/A | 57,936,000.00 | 56,579,000.00 | 186,880,000.00 |
| Property Plant And Equipment | N/A | 703,000.00 | 1,381,000.00 | 4,152,000.00 |
| Goodwill | N/A | 36,268,000.00 | 33,870,000.00 | 99,961,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 20,965,000.00 | 21,328,000.00 | 82,767,000.00 |
| Current Assets | N/A | 29,797,000.00 | 15,159,000.00 | 28,932,000.00 |
| Inventories | N/A | 7,661,000.00 | 7,013,000.00 | 8,117,000.00 |
| Current Trade Receivables | N/A | 1,460,000.00 | 1,348,000.00 | 4,731,000.00 |
| Cash and cash equivalents | N/A | 18,945,000.00 | 2,864,000.00 | 13,641,000.00 |
| Balances With Banks | 485,000.00 | 18,945,000.00 | 2,864,000.00 | N/A |
| Equity And Liabilities | N/A | 87,733,000.00 | 71,738,000.00 | 215,812,000.00 |
| Equity | 14,542,000.00 | 20,349,000.00 | -14,122,000.00 | 138,306,000.00 |
| Issued Capital | N/A | N/A | 5,097,000.00 | 13,908,000.00 |
| Other Reserves | N/A | N/A | -19,219,000.00 | 124,398,000.00 |
| Liabilities | N/A | 67,384,000.00 | 85,860,000.00 | 77,506,000.00 |
| Noncurrent Liabilities | N/A | 57,449,000.00 | 13,581,000.00 | 5,276,000.00 |
| Longterm Borrowings | N/A | 34,821,000.00 | 0.00 | 946,000.00 |
| Current Liabilities | N/A | 9,935,000.00 | 72,279,000.00 | 72,230,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 3,843,000.00 | 6,163,000.00 | 8,610,000.00 |
| Current Payables On Social Security And Taxes Other Than Income Tax | N/A | 2,348,000.00 | 3,747,000.00 | 6,074,000.00 |
| Current Tax Liabilities Current | N/A | N/A | 0.00 | 51,000.00 |
| Other Current Liabilities | N/A | 3,744,000.00 | 7,848,000.00 | 12,693,000.00 |
| Line item in (nok) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 2,961,000.00 | 24,042,000.00 | 19,521,000.00 |
| Raw Materials And Consumables Used | 1,975,000.00 | 14,524,000.00 | 14,344,000.00 |
| Employee Benefits Expense | 10,891,000.00 | 19,013,000.00 | 28,521,000.00 |
| Depreciation And Amortisation Expense | 3,163,000.00 | 3,463,000.00 | 10,931,000.00 |
| Other Expense By Nature | 15,018,000.00 | 23,586,000.00 | 24,868,000.00 |
| Profit Loss From Operating Activities | -28,087,000.00 | -36,544,000.00 | -59,143,000.00 |
| Finance Income | 3,853,000.00 | 15,711,000.00 | 19,122,000.00 |
| Finance Costs | 12,635,000.00 | 5,488,000.00 | 10,704,000.00 |
| Profit Loss Before Tax | -36,868,000.00 | -26,321,000.00 | -50,725,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | 76,000.00 |
| Profit (loss) | -36,868,000.00 | -26,321,000.00 | -50,801,000.00 |
| Line item in (nok) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | -36,868,000.00 | -26,321,000.00 | -50,801,000.00 |
| Adjustments For Decrease Increase In Inventories | -1,844,000.00 | 145,000.00 | -294,000.00 |
| Cash Flows From Used In Operating Activities | -21,641,000.00 | -22,126,000.00 | -51,334,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 0.00 | 54,002,000.00 |
| Cash Flows From Used In Investing Activities | -8,077,000.00 | -4,886,000.00 | -58,370,000.00 |
| Proceeds From Issuing Shares | 41,392,000.00 | 0.00 | 155,597,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 124,000.00 | 429,000.00 | 1,390,000.00 |
| Cash Flows From Used In Financing Activities | 48,169,000.00 | 16,079,000.00 | 120,940,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 9,000.00 | -5,149,000.00 | -460,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 18,460,000.00 | -16,081,000.00 | 10,777,000.00 |
| Cash and cash equivalents | 18,945,000.00 | 2,864,000.00 | 13,641,000.00 |
Please note that some sums might not add up.
NO0010865009
LEI9845005F38B74FFJ1B65
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.